The EPCS Act "reflects federal policymakers' focus on upstream solutions to the opioid epidemic by employing already-existing e-Prescribing technology that is proven and usable," said Sean Kelly, MD, Imprivata's chief medical officer.[Register Now: Upcoming HIMSS Healthcare Security Forum] "Six states have enacted legislation mandating electronic prescribing of controlled substances," noted Kelly, who's also an emergency room doctor at Boston's Beth Israel Deaconess Medical Center.
At a December Senate Judiciary Committee hearing, Joseph T.
Rannazzisi, deputy assistant administrator of the DEA office of diversion control, assured the committee that DEA was dedicated to issuing e-prescription rules but refused to set a timeline.
The lack of DEA policies regarding e-prescribing of controlled substances (EPCS) is considered a key hurdle to more widespread adoption.
Many e-prescription advocates note that doctors are unlikely to adopt the technology wholeheartedly before a system can be put in place that also satisfies DEA requirements.
MSMS is the voice of more than 15,000 physicians in Michigan, giving them the resources, education, and clout they need to remain leaders of the health care team and advocates for their patients.